Middle East & Africa Hemostasis & Tissue Sealing Agents Market Size & Outlook
Related Markets
MEA hemostasis & tissue sealing agents market highlights
- The MEA hemostasis & tissue sealing agents market generated a revenue of USD 567.3 million in 2024.
- The market is expected to grow at a CAGR of 9.1% from 2025 to 2030.
- In terms of segment, topical hemostat was the largest revenue generating product in 2024.
- Topical hemostat is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 567.3 million |
| Market revenue in 2030 | USD 954.1 million |
| Growth rate | 9.1% (CAGR from 2025 to 2030) |
| Largest segment | Topical hemostat |
| Fastest growing segment | Topical hemostat |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical hemostat, Adhesive & tissue sealant |
| Key market players worldwide | Johnson & Johnson, Cryolife, Cohera Medical, Pfizer Inc, Becton Dickinson & Co, Baxter International Inc, HyperBranch Medical Technology, Zimmer Biomet Holdings Inc, B. Braun Medical, Smith & Nephew PLC, Advanced Medical Solutions, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, MEA region accounted for 6.5% of the global hemostasis & tissue sealing agents market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,635.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hemostasis & Tissue Sealing Agents Market Scope
Hemostasis & Tissue Sealing Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Advanced Medical Solutions | View profile | 251-500 | Winsford, Somerset, United Kingdom, Europe | http://www.admedsol.com |
| HyperBranch Medical Technology | View profile | 11-50 | Durham, North Carolina, United States, North America | http://hyperbranch.com |
| Cohera Medical | View profile | 1-10 | Pittsburgh, Pennsylvania, United States, North America | http://www.coheramedical.com |
| Cryolife | View profile | 1-10 | Rome, Lazio, Italy, Europe | https://www.cryoliferoma.it |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | http://www.bbraunusa.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Integra Lifesciences Holdings Corp | View profile | 3946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | https://www.integralife.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Middle East & Africa hemostasis & tissue sealing agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemostasis & tissue sealing agents market will help companies and investors design strategic landscapes.
Topical hemostat was the largest segment with a revenue share of 69.47% in 2024. Horizon Databook has segmented the Middle East & Africa hemostasis & tissue sealing agents market based on topical hemostat, adhesive & tissue sealant covering the revenue growth of each sub-segment from 2018 to 2030.
The goal of the Middle East and African healthcare officials is to lower the rate of injuries and chronic diseases in the region. For this purpose, an effective wound management program was designed by the government, which includes collaboration with organizations to raise awareness about wound care.
The WoundsGroup publishes Diabetic Foot Journal in the Middle East, which aims at educating physicians and general public about diabetic foot care. It makes information accessible to people through workshops, conferences, and e-learning platforms.
In April 2015, a two-day program called the Gulf Diabetic Foot Conference (GDFC) was held in Oman. The event was attended by over 400 professionals and exhibitors and had a special focus on wound management.
Reasons to subscribe to Middle East & Africa hemostasis & tissue sealing agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa hemostasis & tissue sealing agents market databook
-
Our clientele includes a mix of hemostasis & tissue sealing agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa hemostasis & tissue sealing agents market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa hemostasis & tissue sealing agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA hemostasis & tissue sealing agents market size, by country, 2018-2030 (US$M)
Middle East & Africa Hemostasis & Tissue Sealing Agents Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
